These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 21282737)
1. ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines. Yu C; Yao Z; Dai J; Zhang H; Escara-Wilke J; Zhang X; Keller ET In Vivo; 2011; 25(1):69-76. PubMed ID: 21282737 [TBL] [Abstract][Full Text] [Related]
2. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157 [TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay. Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744 [TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines. Michishita M; Akiyoshi R; Suemizu H; Nakagawa T; Sasaki N; Takemitsu H; Arai T; Takahashi K Vet J; 2012 Aug; 193(2):508-13. PubMed ID: 22326935 [TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy. Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340 [TBL] [Abstract][Full Text] [Related]
6. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Patrawala L; Calhoun-Davis T; Schneider-Broussard R; Tang DG Cancer Res; 2007 Jul; 67(14):6796-805. PubMed ID: 17638891 [TBL] [Abstract][Full Text] [Related]
7. Aldehyde dehydrogenase activity selects for the holoclone phenotype in prostate cancer cells. Doherty RE; Haywood-Small SL; Sisley K; Cross NA Biochem Biophys Res Commun; 2011 Nov; 414(4):801-7. PubMed ID: 22005464 [TBL] [Abstract][Full Text] [Related]
8. ALDH high adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis. Sun S; Wang Z Biochem Biophys Res Commun; 2010 Jun; 396(4):843-8. PubMed ID: 20450887 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675 [TBL] [Abstract][Full Text] [Related]
10. Tumorigenic and metastatic activity of human thyroid cancer stem cells. Todaro M; Iovino F; Eterno V; Cammareri P; Gambara G; Espina V; Gulotta G; Dieli F; Giordano S; De Maria R; Stassi G Cancer Res; 2010 Nov; 70(21):8874-85. PubMed ID: 20959469 [TBL] [Abstract][Full Text] [Related]
11. Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line. Rowehl RA; Crawford H; Dufour A; Ju J; Botchkina GI Cancer Genomics Proteomics; 2008; 5(6):301-10. PubMed ID: 19287071 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells. Croker AK; Allan AL Breast Cancer Res Treat; 2012 May; 133(1):75-87. PubMed ID: 21818590 [TBL] [Abstract][Full Text] [Related]
13. Prostate cancer stem/progenitor cells: identification, characterization, and implications. Tang DG; Patrawala L; Calhoun T; Bhatia B; Choy G; Schneider-Broussard R; Jeter C Mol Carcinog; 2007 Jan; 46(1):1-14. PubMed ID: 16921491 [TBL] [Abstract][Full Text] [Related]
14. Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity. Wang L; Park P; Zhang H; La Marca F; Lin CY Int J Cancer; 2011 Jan; 128(2):294-303. PubMed ID: 20309879 [TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of cancer stem cells in human prostate cancer cells. Lee EK; Cho H; Kim CW Biochem Biophys Res Commun; 2011 Aug; 412(2):279-85. PubMed ID: 21820414 [TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis for detection of tumor-initiating cells in feline mammary carcinoma cell lines. Michishita M; Otsuka A; Nakahira R; Nakagawa T; Sasaki N; Arai T; Takahashi K Vet Immunol Immunopathol; 2013 Nov; 156(1-2):73-81. PubMed ID: 24041801 [TBL] [Abstract][Full Text] [Related]
18. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer. Palapattu GS; Wu C; Silvers CR; Martin HB; Williams K; Salamone L; Bushnell T; Huang LS; Yang Q; Huang J Prostate; 2009 May; 69(7):787-98. PubMed ID: 19189306 [TBL] [Abstract][Full Text] [Related]
19. CD44 and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess cancer stem-like cell characteristics. Noto Z; Yoshida T; Okabe M; Koike C; Fathy M; Tsuno H; Tomihara K; Arai N; Noguchi M; Nikaido T Oral Oncol; 2013 Aug; 49(8):787-95. PubMed ID: 23768762 [TBL] [Abstract][Full Text] [Related]
20. Isolation of stem-like cells from spontaneous feline mammary carcinomas: phenotypic characterization and tumorigenic potential. Barbieri F; Wurth R; Ratto A; Campanella C; Vito G; Thellung S; Daga A; Cilli M; Ferrari A; Florio T Exp Cell Res; 2012 Apr; 318(7):847-60. PubMed ID: 22366263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]